Regen BioPharma, Inc.
RGBP
$0.026
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -97.09% | -97.70% | -99.92% | -99.42% | 8,728.57% |
| Total Receivables | 163.93% | 277.08% | 894.31% | -- | 18.76% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -99.15% | -94.23% | 926.00% | 543.00% | 333.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.52% | 23.33% | 22.50% | 22.06% | 143.45% |
|
|
|||||
| Total Current Assets | 17.52% | 23.33% | 22.50% | 22.06% | 143.45% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 15.63% | 20.38% | 20.00% | -49.77% | -40.32% |
|
|
|||||
| Total Accounts Payable | 3.74% | 13.09% | -18.55% | 0.00% | 0.00% |
| Total Accrued Expenses | 6.73% | 6.55% | 2.71% | 1.21% | 1.99% |
| Short-term Debt | 21.49% | 319.12% | 114.14% | 204.86% | 115.54% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 54.01% | 51.49% | 46.03% | -1.96% | -1.96% |
| Total Finance Division Other Current Liabilities | 8.73% | 5.61% | 9.88% | -4.77% | -4.15% |
| Total Other Current Liabilities | 8.73% | 5.61% | 9.88% | -4.77% | -4.15% |
| Total Current Liabilities | 12.85% | 13.43% | 11.88% | 1.20% | 0.26% |
|
|
|||||
| Total Current Liabilities | 12.85% | 13.43% | 11.88% | 1.20% | 0.26% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 21.49% | 319.12% | 114.14% | 204.86% | 115.54% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.85% | 10.37% | 8.69% | -1.58% | 0.26% |
|
|
|||||
| Common Stock & APIC | 2.07% | 2.74% | 4.04% | 5.30% | 5.55% |
| Retained Earnings | -3.77% | -3.61% | -4.15% | -4.39% | -4.77% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -12.77% | -10.11% | -8.37% | -1.78% | -2.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -12.77% | -10.11% | -8.37% | -1.78% | -2.56% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.76% | -10.09% | -8.35% | -1.76% | -2.56% |
|
|
|||||